Fundraising Fox

Henrijette Richter

Investor

Managing Partner at Sofinnova Partners

Paris, France

Writes $100K – $5M checks · typically $1.5M

About

Managing Partner at Sofinnova Partners and member of the Sofinnova Capital Strategy team, its early-stage biotech and medtech fund. She joined in 2014 and has led life science investments including HAYA Therapeutics, Muna Therapeutics, NodThera, and Delinia (acquired by Celgene). Previously she helped build Novo Seeds from its 2007 founding and began her venture career at Sunstone Capital.

Invests in

BiotechMedical Devices

Experience

  1. Sofinnova PartnersManaging Partnercurrent2017 — presentGreater Paris Metropolitan Region
  2. Sofinnova PartnersPartner2014 — 2017Greater Paris Metropolitan Region
  3. Mozart Therapeutics, IncBoard Membercurrent2021 — presentSeattle, Washington, United States
  4. Nitrase TherapeuticsBoard Membercurrent2020 — presentSan Francisco, California, United States
  5. Nitrase TherapeuticsBoard Membercurrent2020 — presentSan Francisco, California, United States
  6. Muna TherapeuticsBoard Membercurrent2021 — presentCopenhagen, Capital Region of Denmark, Denmark
  7. Muna TherapeuticsBoard Membercurrent2021 — presentCopenhagen, Capital Region of Denmark, Denmark
  8. Twentyeight-Seven TherapeuticsBoard Membercurrent2019 — presentWatertown, Massachusetts, United States
  9. Twentyeight-Seven TherapeuticsBoard Membercurrent2019 — presentWatertown, Massachusetts, United States
  10. NodThera LimitedBoard Membercurrent2019 — present
  11. NodThera LimitedChair Of The Board Of Directors2018 — 2019
  12. iOmx Therapeutics AGMember of The Supervisory Boardcurrent2019 — presentGreater Munich Metropolitan Area
  13. iOmx Therapeutics AGChair Of The Board Of Directors2016 — 2019Greater Munich Metropolitan Area
  14. Asceneuron SABoard Membercurrent2015 — presentLausanne, Vaud, Switzerland
  15. Comet TherapeuticsMember Board Of Directors2017 — 2021
  16. Karolinska DevelopmentMember Board of Directors2014 — 2017Greater Stockholm Metropolitan Area
  17. DeliniaMember of the Board2016 — 2017San Francisco Bay Area and Cambridge Massachusetts
  18. DeliniaFounding Chair of the Board2015 — 2016San Francisco Bay Area and Cambridge, Massachusetts
  19. GUDP, Ministry of Food, Agriculture, and Fisheries of DenmarkMember Board of Directors2010 — 2016Copenhagen Metropolitan Area
  20. LYSOGENEMember Board of Directors2014Greater Paris Metropolitan Region

Education

  1. Harvard Business Schoolexecutive course, Venture Capital and Private Equity2008
  2. Copenhagen Business SchoolExecutive Certificate, Business Administration with focus on Leadership and Business Essentials2005 — 2006
  3. Massachusetts Institute of TechnologyPostdoctoral Fellow, Oncology and Cancer Biology2002 — 2004
  4. Københavns Universitet - University of CopenhagenPhD, Molecular Biology1999 — 2002
  5. Københavns Universitet - University of CopenhagenMSc, Biology1991 — 1999

Skills & more

Investments12Finance5Lifesciences4Research1Biotechnology20Strategy16Funding8Start-ups9Mergers & Acquisitions8Business Strategy16Entrepreneurship9Business Development7
+3 morePharmaceutical IndustryGrantsVenture Capital

Languages English

From Henrijette's professional profile.

Same school

Shared employers

Investments

Investor

Avilex PharmaDeliniaEpiTherapeuticsFreya BiosciencesHAYA TherapeuticsMozart TherapeuticsMuna TherapeuticsNanoPhoria BioscienceNodTheraOrphazyme

Per the firm's website.

Colleagues at Sofinnova Partners